Results 151 to 160 of about 1,389,395 (324)

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

open access: yesMolecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero   +8 more
wiley   +1 more source

Face detection in untrained deep neural networks. [PDF]

open access: yesNat Commun, 2021
Baek S, Song M, Jang J, Kim G, Paik SB.
europepmc   +1 more source

Practical Evaluation of Face Morphing Attack Detection Methods [PDF]

open access: hybrid, 2022
Luuk Spreeuwers   +3 more
openalex   +1 more source

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

open access: yesMolecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou   +5 more
wiley   +1 more source

ViT-Based Face Diagnosis Images Analysis for Schizophrenia Detection [PDF]

open access: gold
Huilin Liu   +11 more
openalex   +1 more source

Automated Attendance Monitoring System using Face Detection and RFID Cards

open access: diamond, 2020
Professor Dr. Shubha Jain   +3 more
openalex   +1 more source

Face detection of migrating learning based on constrained scene [PDF]

open access: diamond, 2022
Xuewen Ding   +5 more
openalex   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Face Spoofing Detection Using Local Graph Structure [PDF]

open access: gold, 2014
Housam Khalifa Bashier   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy